Takayasu arteritis-associated pulmonary hypertension

Journal of Rheumatology

Volumn 42, Issue 3, 2015, Pages 495-503

  Wang, Xu ^a   Dang, Aimin ^a   Chen, Bingwei ^a   Lv, Naqiang ^a   Liu, Qing ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Prognosis; Pulmonary hypertension; Takayasu arteritis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1;

ADULT; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART INDEX; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY STENOSIS; PULMONARY HYPERTENSION; REVASCULARIZATION; SYSTOLIC BLOOD PRESSURE; ADOLESCENT; BLOOD; COMPLICATION; HYPERTENSION, PULMONARY; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIAC CATHETERIZATION; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROGNOSIS; TAKAYASU ARTERITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923923797     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140436     Document Type: Article

References (37)

1. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation 1989;80:429-37.
2. Matsubara O, Kuwata T, Nemoto T, Kasuga T, Numano F. Coronary artery lesions in Takayasu arteritis: pathological considerations. Heart Vessels Suppl 1992;7:26-31.
3. Brugiere O, Mal H, Sleiman C, Groussard O, Mellot F, Fournier M. Isolated pulmonary arteries involvement in a patient with Takayasu's arteritis. Eur Respir J 1998;11:767-70.
4. Sharma S, Kamalakar T, Rajani M, Talwar KK, Shrivastava S. The incidence and patterns of pulmonary artery involvement in Takayasu's arteritis. Clin Radiol 1990;42:177-81.
5. Fukuda Y, Shirai K, Takamiya Y, Nathan M, Mito T, Yamagi D, et al. Isolated pulmonary arterial stenosis caused by Takayasu's arteritis in an elderly male. J Cardiol 2008;51:196-200.
6. Nakajima N, Masuda M, Imamaki M, Ishida A, Tanabe N, Kuriyama T. A case of pulmonary artery bypass surgery for a patient with isolated Takayasu pulmonary arteritis and a review of the literature. Ann Thorac Cardiovasc Surg 2007;13:267-71.
7. Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, et al. Takayasu's arteritis in Turkey - clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009;27 Suppl 52:S59-64.
8. Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998;66 Suppl 1:S85-90.
9. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
10. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126 Suppl:14S-34S.
11. Fisher MR, Forfia PR, Chamera E, Housten-Harris T, Champion HC, Girgis RE. et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-21.
12. Qanadli SD, El Hajjam M, Vieillard-Baron A, Joseph T, Mesurolle B, Oliva VL, et al. New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol 2001;176:1415-20.
13. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
14. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl 1992;7:11-7.
15. Andrews J, Mason JC. Takayasu's arteritis-recent advances in imaging offer promise. Rheumatology 2007;46:6-15.
16. Lee SD, Kim DS, Shim TS, Lim CM, Koh Y, Kim WS, et al. Nitric oxide and molsidomine in the management of pulmonary hypertension in Takayasu's arteritis. Chest 2001;119:302-7.
17. Lin MJ, Leung GP, Zhang WM, Yang XR, Yip KP, Tse CM, et al. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 2004;95:496-505.
18. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 2000;47:97-106.
19. Kabins SW, Fridman J, Kandelman M, Weisberg H. Effect of sympathectomy on pulmonary embolism-induced lung edema. Am J Physiol 1962;202:687-9.
20. Leech JA, Onal E, Baer P, Lopata M. Determinants of hypercapnia in occlusive sleep apnea syndrome. Chest 1987;92:807-13.
21. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, Schultheiss HP, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 2001;120:1562-9.
22. Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J 2008;32:503-12.
23. Akazawa H, Ikeda U, Kuroda T, Shimada K. Plasma endothelin-1 levels in Takayasu's arteritis. Cardiology 1996;87:303-5.
24. de Souza AW, Ataíde Mariz H, Torres Reis Neto E, Diniz Arraes AE, da Silva NP, Sato EI. Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients. Clin Rheumatol 2009;28:379-83.
25. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006;113:2011-20.
26. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
27. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000;101:2803-9.
28. Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000;36:2126-31.
29. Wensel R, Opitz CF, Anker SD, Winkler J, Höffken G, Kleber FX, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319-24.
30. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 2012;159:14-20.
31. Shimony A, Fox BD, Langleben D, Rudski LG. Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension. Can J Cardiol 2013;29:678-82.
32. Blyth KG, Groenning BA, Mark PB, Martin TN, Foster JE, Steedman T, et al. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J 2007;29:737-44.
33. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-21.
34. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation 2004;110:1308-12.
35. Wilson SR, Ghio S, Scelsi L, Horn EM. Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension). Prog Cardiovasc Dis 2012;55:104-18.
36. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
37. Ueno M. Antiplatelet therapy in the treatment of Takayasu arteritis. Circ J 2010;74:1079-80.